Sofinnova Investments, Inc. Gilead Sciences, Inc. Transaction History

Sofinnova Investments, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$59.54 - $68.01 $28.7 Million - $32.8 Million	482,400 New	482,400 $29.8 Million
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $25.1 Million - $31.5 Million	-403,494 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$72.34 - $84.0 $29.2 Million - $33.9 Million	403,494 New	403,494 $31 Million
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $13.3 Million - $14.9 Million	-213,331 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $12.9 Million - $16.9 Million	213,331 New	213,331 $13.3 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.